Halozyme Therapeutics
HALO
#2327
Rank
S$10.44 B
Marketcap
S$88.09
Share price
1.91%
Change (1 day)
27.66%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): S$0.60 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are S$1.39 Billion. a decrease over its 2024 earnings that were of S$0.71 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 S$0.59 B-16.2%
2024 S$0.71 B59.94%
2023 S$0.44 B39.94%
2022 S$0.31 B0.16%
2021 S$0.31 B92.2%
2020 S$0.16 B-278.96%
2019 -S$92.61 Million-9.45%
2018 -S$0.11 Billion-229.51%
2017 S$78.96 M-160.48%
2016 -S$0.14 Billion216.03%
2015 -S$41.31 Million-52.86%
2014 -S$87.64 Million-18.09%
2013 -S$0.11 Billion55.88%
2012 -S$68.64 Million169.94%
2011 -S$25.43 Million-63.44%
2010 -S$69.54 Million-7.19%
2009 -S$74.93 Million15.91%
2008 -S$64.64 Million83.89%
2007 -S$35.16 Million78.1%
2006 -S$19.74 Million16%
2005 -S$17.02 Million45.24%
2004 -S$11.72 Million682.42%
2003 -S$1.5 Million1659.12%
2002 -S$0.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.29 B 5,464.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$13.57 B 2,168.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.89 B 6,566.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.81 B 1,540.37%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-S$0.66 Billion-208.81%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
S$1.8 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA